Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Mul-1867 shows promising activity against multidrug-resistant Pseudomonas aeruginosa

April 14, 2016

Researchers present results from in vitro and in vivo studies of WCK-4282

April 14, 2016

Riboscience divulges respiratory syncytial virus RNA replication inhibitors

April 14, 2016

FDA grants orphan drug designation for ATI-1501

April 14, 2016

FDA grants orphan drug designation to TGV-Inhalonix's Mul-1867

April 13, 2016

Phase Ia study evaluates Ebola virus vaccination with VRC-EBOADC076-00-VP followed by MVA-EBOZ

April 13, 2016

BTA-585 enters phase IIa trial for the treatment of RSV infections

April 12, 2016

Encouraging results seen in phase II murepavadin study

April 12, 2016

Data reported from phase III study of surotomycin for CDAD

April 12, 2016

Immunogenicity and safety of MG-1109

April 12, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.